Presentation TCT 2018 Shared Decision-making in NVAF: The Patients Perspective Presenter: James B. Hermiller Jr, David Hildick-Smith, Megan Coylewright September 24, 2018
Presentation TCT 2018 Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants! Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr. September 24, 2018
Presentation TCT 2018 Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure! Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt September 24, 2018
Presentation TCT 2018 Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler September 24, 2018
Presentation TCT 2018 A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC? Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies September 24, 2018
Presentation TCT 2018 TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation Presenter: Horst Sievert, Brian K. Whisenant, Fabian Nietlispach September 23, 2018
Presentation TCT 2018 TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation Presenter: Anibal A. Damonte September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News ESC 2018 Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI Michael O'Riordan August 25, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge Michael O'Riordan August 08, 2018
News Industry News Boston Scientific Announces Agreement to Acquire Claret Medical, Inc. July 24, 2018
News Conference News The Structural Heart Disease Summit 2018 Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions Shelley Wood June 22, 2018
Presentation The Structural Heart Disease Summit 2018 A Rare Case of Platypnea-Orthodeoxia Syndrome Developing After Atrial Fibrillation Ablation Necessitating Percutaneous Closure of the Septal Puncture Site Presenter: Horst Sievert, Robert J. Sommer, Nadim Geloo, MD June 22, 2018
Presentation The Structural Heart Disease Summit 2018 An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC Presenter: Amar Krishnaswamy June 21, 2018
Presentation The Structural Heart Disease Summit 2018 European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC Presenter: Fabian Nietlispach June 21, 2018
Presentation The Structural Heart Disease Summit 2018 A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks Presenter: James B. Hermiller Jr June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How) Presenter: Hüseyin Ince June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions Presenter: Anita Asgar June 21, 2018